Skip to main content

1 Result(s)

within English Remove this filter Biomedicine Remove this filter Immunology Remove this filter Medical Microbiology Remove this filter Ya-nan Huo Remove this filter

and

  1. No Access

    Article

    A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk

    The current study evaluated the efficacy and safety of a denosumab biosimilar, QL1206 (60 mg), compared to placebo in postmenopausal Chinese women with osteoporosis and high fracture risk. At 31 study centers ...

    Hao Zhang, Jie-mei Gu, Ai-jun Chao, Qun Cheng, Dong-hui Teng… in Acta Pharmacologica Sinica (2023)